logo
Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors

Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors

Business Wire17-05-2025
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, announced the appointment of James Huang and Nachi Subramanian to its Board of Directors, effective following the completion the Company's previously announced $16 million offering that was announced on May 15, 2025. The offering closed on May 16, 2025.
Mr. Huang has over 37 years of biotech experience and is the Founder and Managing Partner of Panacea Venture. Prior to Panacea Venture, Mr. Huang was a Managing Partner at Kleiner Perkins (KPCB) China where he focused on the firm's life sciences practice, and a managing partner at Vivo Ventures where he led numerous investments in China. He was also the president of Anesiva, Inc., a biopharmaceutical company focused on pain-management treatments. Earlier in his career, he held senior roles in business development, sales, marketing, and research and development with Tularik Inc. (acquired by Amgen), GlaxoSmithKline LLC, Bristol-Myers Squibb and ALZA Corp. (acquired by Johnson & Johnson). Additionally, Mr. Huang serves as a member of the board of directors of Kindstar Globalgene Technology, Inc., Connect Biopharma Holdings Limited, Lee's Pharmaceutical Holdings Limited and several private companies. He received an M.B.A. from the Stanford Graduate School of Business and a B.S. degree in chemical engineering from the University of California, Berkeley.
Nachi Subramanian has served as a Managing Director at the Redmile Group since December 2021. He previously spent fourteen years at J.P. Morgan, where he held senior roles across the Private Markets and Global Cash Equities businesses. Nachi began his career in Institutional Equities at Bear Stearns. He holds a B.A. in Political Science and Economics from the University of California, Irvine.
About Atara Biotherapeutics, Inc.
Atara is a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr Virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases. Atara is headquartered in Southern California.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Netflix Raises Forecast After Ad Tech Success
Netflix Raises Forecast After Ad Tech Success

Yahoo

time3 minutes ago

  • Yahoo

Netflix Raises Forecast After Ad Tech Success

Netflix (NASDAQ:NFLX) lifts full?year revenue guidance to $45.2 billion after a stronger?than?expected second quarter and successful global rollout of its Ad Suite. In Q2, management raised the 2025 revenue range to $44.8 billion$45.2 billion, up about $1 billion at the midpoint versus the prior $43.5 billion$44.5 billion guide. Reported operating margin now targets 30%, a full point above last year's 29%, with FX neutral margin also up 50 basis points. Co?CEO Gregory Peters said retention remains stable and industry?leading, while CFO Spencer Neumann noted that healthy member growth and ad strength beyond FX tailwinds drove the tighter range. Netflix Ad Suite is live worldwide, and early results align with expectations, Peters added. Ad revenue is on pace to roughly double year?over?year as improved ad tech and advertiser demand gain momentum. Co?CEO Ted Sarandos highlighted a steady drumbeat of returning hits like Squid Game, Wednesday and Stranger Things alongside a robust slate of upcoming movies, series and games to keep engagement high. This article first appeared on GuruFocus.

Netflix's Blockbuster Profits Overshadowed By 'Anemic' Engagement
Netflix's Blockbuster Profits Overshadowed By 'Anemic' Engagement

Yahoo

time3 minutes ago

  • Yahoo

Netflix's Blockbuster Profits Overshadowed By 'Anemic' Engagement

Despite delivering a robust second-quarter earnings report that surpassed analyst expectations and raised full-year guidance, Netflix (NASDAQ:NFLX) stock dipped over 5% on Friday, leaving investors to weigh strong financials against underlying concerns. The company reported second-quarter revenue of $11.08 billion, up 16% year-over-year (Y/Y). The revenue total beat a Street consensus estimate of $11.04 billion. The company reported second-quarter earnings per share of $7.19, beating a Street consensus estimate of $7.06. The quarter's operating margins were 34%, beating the company's attributed more members, higher pricing, and increased advertising revenue to helping boost revenue and operating margins. Netflix expects third-quarter revenue of $11.526 billion, up 17% Y/Y, and earnings per share of $6.87. Both figures are above Street estimates. The company also raised full-year revenue guidance to $44.8 billion-$45.2 billion, up from a previous range of $43.5 billion-$44.5 billion. Netflix is guiding for operating margins of 29.5% for the whole year. Wall Street Analysts Weigh In In the wake of Netflix's recent financial disclosures, several prominent Wall Street analysts have issued updated ratings and price forecasts for the streaming company. Rosenblatt's Barton Crockett maintained a Buy rating, nudging his price forecast up a dollar from $1,514 to $1,515. Similarly, Needham's Laura Martin reiterated a Buy rating with a $1,500 price forecast. On the other hand, JP Morgan's Doug Anmuth kept a Neutral rating but increased his price forecast from $1,230 to $1,300. Finally, Bank of America Securities analyst Jessica Reif Ehrlich reiterated her Buy rating, setting a price forecast of $1,490. Rosenblatt's Bullish Stance Crockett responded positively to Netflix's second-quarter 2025 results and raised guidance, highlighting steady financial performance and optimism for the year's second half despite mixed engagement trends. The analyst noted that Netflix's quarterly revenue exceeded guidance by $44 million due to currency tailwinds. He said the constant currency growth of 17% aligned with forecasts, with subscriber growth, ads, and pricing driving revenue. Crockett noted that operating income rose 45% Y/Y, beating guidance by $100 million on substantial margin expansion. While Netflix no longer reports subscriber numbers, the analyst flagged mixed engagement data. Total hours streamed rose just 1% Y/Y in the first half of 2025, down from 4.5% in the second half of 2024, raising questions about Netflix's claim to chase the remaining 80% of global TV viewing time, he noted. However, Crockett expects engagement to improve in the second half of 2025, with June finishing strong due to Squid Game 3. Anticipated releases like Stranger Things, Wednesday, Knives Out 3, Happy Gilmore 2, and Christmas NFL games are likely to boost viewership, as per the analyst. Netflix raised its fiscal 2025 revenue forecast, reflecting that optimism, Crockett noted. It also lifted operating margin expectations to 30% (from 29%) and raised free cash flow guidance. The analyst highlighted ad revenue doubling Y/Y as another key driver. Needham's Cautious Praise Martin largely praised Netflix's strong quarterly results and upbeat guidance but flagged concerns around engagement trends, sports strategy, and content bets that led to a muted stock reaction after hours. The analyst flagged weak engagement growth in the quarter, with total viewing time appearing flat or declining per user. She characterized engagement growth in the second quarter of 2025 as anemic, implying a year-over-year decline on a per-person basis. She emphasized that improving engagement is critical for pricing power, especially as Netflix no longer reports subscriber numbers or ARPU. Netflix's push to partner with YouTube creators and video podcasters impressed Martin, who noted it as a strategic shift to stay competitive with YouTube's content ecosystem. The analyst cited the TF1 deal in France as a smart test case for acquiring local content at scale and low cost. She noted Netflix's optimism about GenAI tools, which will improve content quality, discovery, and ad targeting. The company's dismissive stance on live sports raised eyebrows, and Martin questioned the decision given sports' proven impact on engagement and subscriber retention in the broader streaming space. On user experience, the analyst welcomed the long-overdue UI/UX overhaul, noting Netflix's efforts to modernize navigation to reflect its expanded offerings, such as video games and live shows. Despite its financial strength, Netflix reiterated it has no plans to acquire legacy media networks, preferring to return cash to shareholders, a move Martin noted as a sign of financial discipline. While Netflix plans to ramp up video game investment based on subscriber retention metrics, the analyst noted early adoption has fallen short of expectations. J.P. Morgan's Neutral View Anmuth viewed Netflix's quarterly results and full-year guidance as solid, reflecting strong execution across content, advertising, and monetization. However, the stock traded lower after hours as expectations were already high. While engagement rose just 1% in the first half of 2025, the analyst expects a meaningful ramp in the second half with the return of major titles like Squid Game S3, Stranger Things S5, and Wednesday S2. He noted that this slate could unlock stronger per-user engagement and pricing power. Anmuth emphasized that Netflix is well-positioned to become a 'global TV' leader by expanding into verticals like live, broadcast, and animation, while boosting scripted and unscripted formats. The analyst also spotlighted Netflix's growing advertising business. Ad revenue will likely double in 2025 to $2.9 billion, driven by expanding third-party DSP partnerships (e.g., Google, Yahoo, Xandr) and the rollout of the Netflix Ads Suite and interactive formats. While advertising is still catching up to Netflix's user base, Anmuth noted that ad-tier monetization is improving. He said they project ad-tier subscribers could reach 60 million by year-end, representing over 130 million monthly active users. Despite the strong guide and bullish tone, he remained cautious in the near term, as buy-side expectations are already priced in. Bank of America Securities' Continued Optimism Ehrlich reacted positively to Netflix's quarterly 2025 results and raised guidance, reinforcing her bullish stance on the stock while acknowledging that high investor expectations may have muted the immediate market response. The analyst praised Netflix for delivering another strong quarter driven by rising membership, price hikes, and ad revenue. She noted broad-based regional strength, with all markets delivering double-digit FX-neutral revenue gains. Netflix raised full-year 2025 revenue guidance, citing favorable currency trends, subscriber gains, and ad momentum. While Netflix shares have surged over 40% year-to-date and now trade near 40x forward earnings, Ehrlich noted the company remains well-positioned for continued outperformance, supported by a strong brand, global scale, and growing ad and live content opportunities. Why the Stock Dipped: Investor Expectations and Engagement Concerns The paradoxical dip in Netflix's stock despite strong financials is largely attributed to elevated investor expectations. While the company's performance was excellent, some analysts and investors might have hoped for an even more bullish outlook, especially given the stock's significant appreciation year-to-date (over 40%). Concerns over engagement trends, specifically the modest 1% Y/Y increase in total hours streamed in the first half of 2025, also played a role. Additionally, the company's warning of lower operating margins in the second half of 2025 due to increased content amortization and sales and marketing costs for a larger content slate may have contributed to investor caution. Price Action: NFLX stock is trading lower by 4.64% to $1,215.18 at last check Friday. Image via Shutterstock Latest Ratings for NFLX Date Firm Action From To Mar 2022 Wedbush Upgrades Underperform Neutral Jan 2022 Citigroup Upgrades Neutral Buy Jan 2022 Rosenblatt Maintains Neutral View More Analyst Ratings for NFLX View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? NETFLIX (NFLX): Free Stock Analysis Report This article Netflix's Blockbuster Profits Overshadowed By 'Anemic' Engagement originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Five Star Bancorp Declares Second Quarter Cash Dividend
Five Star Bancorp Declares Second Quarter Cash Dividend

Yahoo

time3 minutes ago

  • Yahoo

Five Star Bancorp Declares Second Quarter Cash Dividend

RANCHO CORDOVA, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) ('Five Star' or the 'Company'), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the "Bank"), announced today the declaration of a cash dividend of $0.20 per share on the Company's voting common stock. The dividend is expected to be paid on August 11, 2025, to shareholders of record as of August 4, 2025. About Five Star BancorpFive Star is a bank holding company headquartered in Rancho Cordova, California. Five Star operates through its wholly owned banking subsidiary, Five Star Bank. The Bank has eight branches in Northern California. For more information, visit Special Note Concerning Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent plans, estimates, objectives, goals, guidelines, expectations, intentions, projections, and statements of the Company's beliefs concerning future events, business plans, objectives, expected operating results, and the assumptions upon which those statements are based. Forward-looking statements include without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements, and are typically identified with words such as 'may,' 'could,' 'should,' 'will,' 'would,' 'believe,' 'anticipate,' 'estimate,' 'expect,' 'aim,' 'intend,' 'plan,' or words or phases of similar meaning. The Company cautions that the forward-looking statements are based largely on the Company's expectations and are subject to a number of known and unknown risks and uncertainties that are subject to change based on factors which are, in many instances, beyond the Company's control. Such forward-looking statements are based on various assumptions (some of which may be beyond the Company's control) and are subject to risks and uncertainties, which change over time, and other factors, which could cause actual results to differ materially from those currently anticipated. New risks and uncertainties may emerge from time to time, and it is not possible for the Company to predict their occurrence or how they will affect the Company. If one or more of the factors affecting the Company's forward-looking information and statements proves incorrect, then the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, forward-looking information and statements contained in this press release. Therefore, the Company cautions you not to place undue reliance on the Company's forward-looking information and statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the three months ended March 31, 2025, in each case under the section entitled 'Risk Factors,' and other documents filed by the Company with the Securities and Exchange Commission from time to time. The Company disclaims any duty to revise or update the forward-looking statements, whether written or oral, to reflect actual results or changes in the factors affecting the forward-looking statements, except as specifically required by law. Investor Contact:Heather C. Luck, Chief Financial OfficerFive Star Bancorp(916) 626-5008hluck@ Media Contact:Shelley R. Wetton, Chief Marketing OfficerFive Star Bancorp(916) 284-7827swetton@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store